Literature DB >> 2249209

True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy.

A Talerman1, M S Verp, E Senekjian, T Gilewski, N Vogelzang.   

Abstract

The first case (to the authors' knowledge) is reported of a true hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, a 46, XX/46,XY karyotype, and a successful pregnancy. The true hermaphroditism was diagnosed during infancy. The patient was subsequently found to have a gonadoblastoma and a microscopic dysgerminoma in the gonad diagnosed as an ovotestis and excised during infancy. The successful pregnancy occurred when the patient was 29 years old. A year later a large gonadal tumor affecting the remaining gonad was excised. The gonad was found to be an ovotestis, and the tumor was a dysgerminoma arising from a gonadoblastoma. This case further emphasizes the malignant potential of the Y chromosome in patients with abnormal gonads.

Entities:  

Mesh:

Year:  1990        PMID: 2249209     DOI: 10.1002/1097-0142(19901215)66:12<2668::aid-cncr2820661234>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Successful second delivery outcome using refrozen thawed testicular sperm from an infertile male true hermaphrodite with a 46, XX/46, XY karyotype: case report.

Authors:  Nobuo Sugawara; Yasuyuki Kimura; Yasuhisa Araki
Journal:  Hum Cell       Date:  2012-12-01       Impact factor: 4.174

Review 2.  True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology.

Authors:  G Krob; A Braun; U Kuhnle
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

3.  Possible misdiagnosis of 46,XX testicular disorders of sex development in infertile males.

Authors:  Tong Chen; Linlin Tian; Xianlong Wang; Demin Fan; Gang Ma; Rong Tang; Xujun Xuan
Journal:  Int J Med Sci       Date:  2020-05-11       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.